{"protocolSection": {"identificationModule": {"nctId": "NCT03102437", "orgStudyIdInfo": {"id": "CP OPT2017-004"}, "organization": {"fullName": "Impulse Dynamics", "class": "INDUSTRY"}, "briefTitle": "Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System", "officialTitle": "FIX-HF-5CA: Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%", "acronym": "FIX-HF-5CA"}, "statusModule": {"statusVerifiedDate": "2021-02", "overallStatus": "TERMINATED", "whyStopped": "The primary objective of the protocol was to allow ongoing access to treatment of patients suffering from moderate to severe heart failure at selected investigational sites until the PMA was approved by the FDA for the OPTIMIZER System.", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-07-01", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-12-16", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-12-16", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-03-23", "studyFirstSubmitQcDate": "2017-03-30", "studyFirstPostDateStruct": {"date": "2017-04-05", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2020-11-13", "resultsFirstSubmitQcDate": "2021-11-21", "resultsFirstPostDateStruct": {"date": "2021-11-23", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-11-21", "lastUpdatePostDateStruct": {"date": "2021-11-23", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Impulse Dynamics", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true}, "descriptionModule": {"briefSummary": "This is a multicenter, prospective, single-arm Continued Access study of the Optimizer Smart System with CCM therapy.", "detailedDescription": "The Continued Access study is a prospective, non-randomized, multi-center study designed to allow controlled access to the Optimizer Smart System until the PMA order has been issued by the FDA."}, "conditionsModule": {"conditions": ["Heart Failure", "Congestive Heart Failure", "Chronic Heart Disease", "CHF"], "keywords": ["Cardiac Contractility Modulation", "CCM", "FIX-HF-5CA", "Continued Access"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "interventionModelDescription": "Continued Access", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 106, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Optimizer Smart System", "type": "EXPERIMENTAL", "description": "All eligible subjects will have the Optimizer Smart System implanted and receive cardiac contractility modulation therapy (CCM).", "interventionNames": ["Device: Optimizer Smart System"]}], "interventions": [{"type": "DEVICE", "name": "Optimizer Smart System", "description": "The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day.", "armGroupLabels": ["Optimizer Smart System"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Observed Mortality Comparison to the Predicted Probability of Mortality", "description": "The FIX-HF-5CA Study was unofficially intended to serve as the Post-Approval Study (PAS) with the intention of collecting 3 year observed mortality data and comparing that to the predicted probability of mortality derived from two validated heart failure models \\[MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) and SHFM (Seattle Heart Failure Model)\\]. The objective was to show that the observed prevalence of mortality was not worse than the derived predicted probability of mortality. Upon PMA and PMA Supplement approval of the device, however, FDA and the Sponsor stopped this 5CA study and a new PAS was initiated (NCT03970343). No long-term mortality data or final analysis was collected for this study.", "timeFrame": "2 years 6 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Subjects who are 18 years of age or older\n2. Subjects who have a baseline ejection fraction greater than or equal to 25% and less than or equal to 45% by echocardiography.\n3. Subjects who, in the opinion of the Investigator (based on the current guidelines for clinical practice), have been treated for heart failure for at least 90 days and are currently receiving appropriate, stable medical therapy during the 30 days prior to enrollment for treatment of heart failure.\n4. Subjects who are in New York Heart Association functional Class III and IV at the time of enrollment.\n5. Subjects who are willing and able to return for all follow-up visits.\n\nExclusion Criteria:\n\n1. Subjects who have a potentially correctible cause of heart failure, such as valvular heart disease or congenital heart disease.\n2. Subjects receiving any form of inotropic support within 30 days before enrollment, including subjects on continuous IV inotrope therapy.\n3. Subjects hospitalized for decompensated heart failure requiring acute treatment with intravenous loop diuretics, IV inotropes or hemofiltration within 30 days before enrollment and baseline testing.\n4. Subjects who have a clinically significant amount of ambient ectopy, defined as more than 8,900 PVCs per 24 hours on baseline Holter monitoring.\n5. Subjects having a PR interval greater than 375ms.\n6. Subjects who are scheduled for a CABG or a PTCA procedure, or who have undergone a CABG procedure within 90 days or a PTCA procedure within 30 days of enrollment.\n7. Subjects who have a biventricular pacing system, an accepted indication for such a device, or a QRS width of 130ms or greater.\n8. Subjects who have had a myocardial infarction within 90 days of enrollment.\n9. Subjects who have mechanical tricuspid valve.\n10. Subjects who have a Left Ventricular Assist Device or prior heart transplant.\n11. Subjects on dialysis.\n12. Subjects who are participating in another experimental protocol.\n13. Subjects who are unable to provide informed consent.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Daniel Burkhoff, MD, PhD", "affiliation": "Impulse Dynamics", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Chan Heart Rhythm Institute", "city": "Mesa", "state": "Arizona", "zip": "85206", "country": "United States", "geoPoint": {"lat": 33.42227, "lon": -111.82264}}, {"facility": "Southwest Cardiology Associates", "city": "Mesa", "state": "Arizona", "zip": "85206", "country": "United States", "geoPoint": {"lat": 33.42227, "lon": -111.82264}}, {"facility": "Cardiovascular Consultants", "city": "Phoenix", "state": "Arizona", "zip": "85027", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "Arizona Arrhythmia Consultants", "city": "Scottsdale", "state": "Arizona", "zip": "85251", "country": "United States", "geoPoint": {"lat": 33.50921, "lon": -111.89903}}, {"facility": "Pima Heart", "city": "Tucson", "state": "Arizona", "zip": "85745", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"facility": "Baptist Health Lexington", "city": "Lexington", "state": "Kentucky", "zip": "40503", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "University of Kentucky", "city": "Lexington", "state": "Kentucky", "zip": "40536", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "Ochsner Clinic Foundation", "city": "New Orleans", "state": "Louisiana", "zip": "70121", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"facility": "Cooper University Hospital", "city": "Camden", "state": "New Jersey", "zip": "08103", "country": "United States", "geoPoint": {"lat": 39.92595, "lon": -75.11962}}, {"facility": "Ohio State University Wexner Medical Center", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "St. Mary Research Institute", "city": "Langhorne", "state": "Pennsylvania", "zip": "19047", "country": "United States", "geoPoint": {"lat": 40.17455, "lon": -74.92267}}, {"facility": "Jefferson Heart Institute", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19047", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Hospital of the University of Pennsylvania", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19104", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Penn Presbyterian Medical Center", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19104", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Guthrie Medical Group at Robert Packer Hospital", "city": "Sayre", "state": "Pennsylvania", "zip": "18840", "country": "United States", "geoPoint": {"lat": 41.97896, "lon": -76.5155}}, {"facility": "UT Southwestern Medical Center", "city": "Dallas", "state": "Texas", "zip": "75390", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "CHRISTUS Trinity Mother Frances Health System", "city": "Tyler", "state": "Texas", "zip": "75701", "country": "United States", "geoPoint": {"lat": 32.35126, "lon": -95.30106}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Optimizer Smart System (3-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 3-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day."}, {"id": "FG001", "title": "Optimizer Smart System (2-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 2-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "70"}, {"groupId": "FG001", "numSubjects": "36"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "65"}, {"groupId": "FG001", "numSubjects": "36"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Optimizer Smart System (3-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 3-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day."}, {"id": "BG001", "title": "Optimizer Smart System (2-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 2-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "70"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "106"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "65", "lowerLimit": "31", "upperLimit": "91"}, {"groupId": "BG001", "value": "66", "lowerLimit": "33", "upperLimit": "84"}, {"groupId": "BG002", "value": "66", "lowerLimit": "31", "upperLimit": "91"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "36"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "44"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "70"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "14"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "59"}, {"groupId": "BG001", "value": "30"}, {"groupId": "BG002", "value": "89"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "2"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "70"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "106"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Observed Mortality Comparison to the Predicted Probability of Mortality", "description": "The FIX-HF-5CA Study was unofficially intended to serve as the Post-Approval Study (PAS) with the intention of collecting 3 year observed mortality data and comparing that to the predicted probability of mortality derived from two validated heart failure models \\[MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) and SHFM (Seattle Heart Failure Model)\\]. The objective was to show that the observed prevalence of mortality was not worse than the derived predicted probability of mortality. Upon PMA and PMA Supplement approval of the device, however, FDA and the Sponsor stopped this 5CA study and a new PAS was initiated (NCT03970343). No long-term mortality data or final analysis was collected for this study.", "populationDescription": "All subjects implanted with the Optimizer System.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "2 years 6 months", "groups": [{"id": "OG000", "title": "Optimizer Smart System (3-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 3-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day."}, {"id": "OG001", "title": "Optimizer Smart System (2-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 2-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "70"}, {"groupId": "OG001", "value": "36"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "0"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "24 Months", "eventGroups": [{"id": "EG000", "title": "Optimizer Smart System (3-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 3-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day.", "deathsNumAffected": 5, "deathsNumAtRisk": 70, "seriousNumAffected": 13, "seriousNumAtRisk": 70, "otherNumAffected": 12, "otherNumAtRisk": 70}, {"id": "EG001", "title": "Optimizer Smart System (2-Lead)", "description": "All eligible subjects will have the Optimizer Smart System 2-Lead implanted and receive cardiac contractility modulation therapy (CCM).\n\nOptimizer Smart System: The Optimizer Smart System delivers non-excitatory cardiac contractility modulating (CCM) electrical signals to the heart muscle. Treatment group subjects receive five non-contiguous one-hour periods of CCM signals per day.", "deathsNumAffected": 0, "deathsNumAtRisk": 36, "seriousNumAffected": 4, "seriousNumAtRisk": 36, "otherNumAffected": 3, "otherNumAtRisk": 36}], "seriousEvents": [{"term": "Optimizer Lead dislodgement", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 36}]}, {"term": "Optimizer Pocket infection", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "Localized Infection", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "ICD or pacemaker System AE", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "Arrhythmias", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "General Medical", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "General Cardiopulmonary event", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 36}]}, {"term": "Neurologic Dysfunction - TIA", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 36}]}, {"term": "Worsening Heart Failure", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}], "otherEvents": [{"term": "Bleeding", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "General Cardiopulmonary Event", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 36}]}, {"term": "Thromboembolism (non-Neurologic)", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "OPTIMIZER pocket stimulation", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 36}]}, {"term": "ICD inappropriate therapy", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 36}]}, {"term": "General Medical", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 8, "numAtRisk": 70}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 36}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "The FIX-HF-5CA Study was unofficially intended to serve as the Post-Approval Study (PAS) with the intention of collecting 3 year data. Upon PMA (3-lead) and PMA Supplement approval (2-lead) of the device, however, FDA and the Sponsor terminated this continued access study and a new PAS was initiated (NCT03970343). No long-term or final analysis was collected for this study."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The Publication Committee shall consist of the National PIs and Impulse Dynamics representatives. All abstracts and papers of the multi-center publications will be reviewed by members of the publication committee and all authors. When appropriate, the publication committee will collect comments and resolve final draft issues. If a paper is rejected, the publication committee and its authors will decide the next course of action."}, "pointOfContact": {"title": "Angela Stagg", "organization": "Impulse Dynamics", "email": "astagg@impulsedynamics.com", "phone": "18453592389"}}}, "documentSection": {"largeDocumentModule": {"noSap": true, "largeDocs": [{"typeAbbrev": "Prot_ICF", "hasProtocol": true, "hasSap": false, "hasIcf": true, "label": "Study Protocol and Informed Consent Form", "date": "2019-03-27", "uploadDate": "2021-02-09T01:11", "filename": "Prot_ICF_001.pdf", "size": 1206274}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2020-12-09", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000006331", "term": "Heart Diseases"}], "ancestors": [{"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9419", "name": "Heart Diseases", "asFound": "Heart Disease", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}